PAUL HARTLEY: Open Payments
NPI 1417911587 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,028 in 83 payments from 20 companies in 2025. Trend: 2023 $1,334 · 2024 $1,636 · 2025 $3,028
Food & beverage: $1,817Travel & lodging: $1,210
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $1,540 |
| AstraZeneca Pharmaceuticals LP | 5 | $439 |
| PFIZER INC. | 19 | $249 |
| Novo Nordisk Inc | 13 | $215 |
| GlaxoSmithKline, LLC. | 9 | $144 |
| Merck Sharp & Dohme LLC | 3 | $58 |
| Abbott Laboratories | 3 | $56 |
| ABBVIE INC. | 3 | $48 |
| Lilly USA, LLC | 2 | $40 |
| Astellas Pharma US Inc | 2 | $39 |
Products named: AIRSUPRA, BREZTRI, TRELEGY ELLIPTA, ELIQUIS, NURTEC ODT, GARDASIL 9, CREON, Wegovy.
Industry payments across PA — which companies pay providers there.
